NASDAQ: TELA - TELA Bio, Inc.

Altı ay boyunca karlılık: -45.85%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı TELA Bio, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.

daha fazla ayrıntı
The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2019-11-08
ISIN US8723811084
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.telabio.com
Цена ао 1.29
Günlük fiyat değişimi: -0% (1.37)
Haftalık fiyat değişimi: -6.8% (1.47)
Aylık fiyat değişimi: -47.31% (2.6)
3 ayda fiyat değişimi: -52.92% (2.91)
Altı ayda fiyat değişimi: -45.85% (2.53)
Yıllık fiyat değişimi: -75.84% (5.67)
3 yılda fiyat değişimi: -88.39% (11.8)
5 yılda fiyat değişimi: -91.43% (15.99)
Yılbaşından bu yana fiyat değişimi: -54.64% (3.02)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 2.55 6
P/BV 7.9 1
P/E 0 0
EV/EBITDA -3.35 0
Toplam: 4.63

Yeterlik

İsim Anlam Seviye
ROA, % -59.79 0
ROE, % -247.15 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.9495 10
Toplam: 7.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 279.56 10
karlılık Ebitda, % 116.13 10
karlılık EPS, % -86.03 0
Toplam: 7
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Essex Woodlands Management Inc. 4110709 16.68
Orbimed Advisors LLC. 2835542 11.5
First Light Asset Management, LLC 2554641 10.36
Nantahala Capital Management, LLC 2195732 8.91
AIGH Capital Management LLC 1377945 5.59
Blackrock Inc. 1078056 4.37
Vanguard Group Inc 998853 4.05
Pentwater Capital Management LP 990000 4.02
SILVERARC CAPITAL MANAGEMENT, LLC 795080 3.23
Federated Hermes, Inc. 712300 2.89

ETFPaylaşmak, %Yıllık karlılık, %Temettüler, %
Jacob Forward ETF 2.05852 43.03 0.15284
iShares Micro-Cap ETF 0.01069 17.09 1.54048
1.0330.060.84



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Antony Koblish Co-founder, President, CEO & Director 1.03M 1966 (59 yıllar)
Mr. Roberto E. Cuca J.D. CFO & COO 674.78k 1968 (57 yıllar)
Mr. Paul Talmo Chief Technology Officer 595.67k 1972 (53 yıl)
Ms. Megan Smeykal VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer N/A 1976 (49 yıllar)
Mr. D. Taylor Ocasio General Counsel & Corporate Secretary N/A
Ms. Jennifer Lou Armstrong Senior Vice President of Human Resources N/A 1970 (55 yıllar)
Mr. Gregory A. Firestone Chief Commercial Officer N/A 1959 (66 yıllar)
Mr. Michael Leonard Senior Vice President of Technical Operations N/A
Mr. Peter C. Murphy Chief Commercial Officer 542.34k 1973 (52 yıl)
Louisa Smith Investor Relations Contact Officer N/A

Adres: United States, Malvern. PA, 1 Great Valley Parkway - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.telabio.com